BioInvent International AB (publ) (LON:0H22)

LON:0H22 Statistics

Total Valuation

LON:0H22 has a market cap or net worth of GBP 165.67 million. The enterprise value is 110.82 million.

Market Cap	165.67M
Enterprise Value	110.82M

Important Dates

The last earnings date was Wednesday, October 29, 2025.

Earnings Date	Oct 29, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	65.80M
Shares Outstanding	n/a
Shares Change (YoY)	-0.14%
Shares Change (QoQ)	+0.26%
Owned by Insiders (%)	0.37%
Owned by Institutions (%)	16.34%
Float	30.82M

Valuation Ratios

PE Ratio	n/a
Forward PE	23.17
PS Ratio	8.57
PB Ratio	3.07
P/TBV Ratio	3.07
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-4.33
EV / Sales	5.61
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-5.35

Financial Position

The company has a current ratio of 7.40, with a Debt / Equity ratio of 0.02.

Current Ratio	7.40
Quick Ratio	7.31
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	-0.04
Interest Coverage	-627.63

Financial Efficiency

Return on equity (ROE) is -38.42% and return on invested capital (ROIC) is -25.41%.

Return on Equity (ROE)	-38.42%
Return on Assets (ROA)	-23.24%
Return on Invested Capital (ROIC)	-25.41%
Return on Capital Employed (ROCE)	-50.88%
Revenue Per Employee	155,895
Profits Per Employee	-206,251
Employee Count	114
Asset Turnover	0.26
Inventory Turnover	n/a

Taxes

In the past 12 months, LON:0H22 has paid 20,606 in taxes.

Income Tax	20,606
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -37.21% in the last 52 weeks. The beta is -0.06, so LON:0H22's price volatility has been lower than the market average.

Beta (5Y)	-0.06
52-Week Price Change	-37.21%
50-Day Moving Average	29.43
200-Day Moving Average	31.55
Relative Strength Index (RSI)	51.97
Average Volume (20 Days)	1,199

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LON:0H22 had revenue of GBP 19.33 million and -25.58 million in losses. Loss per share was -0.39.

Revenue	19.33M
Gross Profit	19.33M
Operating Income	-27.50M
Pretax Income	-25.55M
Net Income	-25.58M
EBITDA	-26.57M
EBIT	-27.50M
Loss Per Share	-0.39

Balance Sheet

The company has 54.51 million in cash and 843,671 in debt, giving a net cash position of 53.67 million.

Cash & Cash Equivalents	54.51M
Total Debt	843,671
Net Cash	53.67M
Net Cash Per Share	n/a
Equity (Book Value)	53.92M
Book Value Per Share	0.82
Working Capital	51.13M

Cash Flow

In the last 12 months, operating cash flow was -20.17 million and capital expenditures -539,236, giving a free cash flow of -20.71 million.

Operating Cash Flow	-20.17M
Capital Expenditures	-539,236
Free Cash Flow	-20.71M
FCF Per Share	n/a

Margins

Gross margin is 100.00%, with operating and profit margins of -142.27% and -132.30%.

Gross Margin	100.00%
Operating Margin	-142.27%
Pretax Margin	-132.19%
Profit Margin	-132.30%
EBITDA Margin	-137.43%
EBIT Margin	-142.27%
FCF Margin	n/a

Dividends & Yields

LON:0H22 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.14%
Shareholder Yield	0.14%
Earnings Yield	-15.44%
FCF Yield	-12.50%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on December 14, 2020. It was a reverse split with a ratio of 0.04.

Last Split Date	Dec 14, 2020
Split Type	Reverse
Split Ratio	0.04

Scores

Altman Z-Score	n/a
Piotroski F-Score	2